Literature DB >> 18090922

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Peter T Nelson1, Gregory A Jicha, Frederick A Schmitt, Huaichen Liu, Daron G Davis, Marta S Mendiondo, Erin L Abner, William R Markesbery.   

Abstract

There is uncertainty regarding the association of cognitive decline in Alzheimer disease (AD) with classic histopathologic features- neurofibrillary tangles (NFTs) and "neuritic" amyloid plaques (NPs). This uncertainty fuels doubts about the diagnostic importance of NFTs and NPs and leads to confusion regarding hypotheses of AD pathogenesis. Three hundred ninety subjects who underwent longitudinal premortem clinical workup and postmortem quantitative neuropathologic assessment served as the group to address this issue. Subjects with concomitant brain disease(s) were analyzed independently to more accurately assess the contribution of distinct pathologies to cognitive decline. More than 60% of patients of all age groups had important non-AD brain pathologies. However, subjects without superimposed brain diseases showed strong correlations between AD-type pathology counts (NFTs > NPs) and premortem Mini-Mental State Examination scores. The observed correlation was stronger in isocortex than in allocortex and was maintained across age groups including patients older than 90 years. A theoretical model is proposed in which our results are interpreted to support the "amyloid cascade hypothesis" of AD pathogenesis. Our data show that there are many important contributory causes to cognitive decline in older persons. However, NFTs and NPs should not be dismissed as irrelevant in AD based on clinicopathologic correlation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090922      PMCID: PMC3034246          DOI: 10.1097/nen.0b013e31815c5efb

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  82 in total

1.  Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Rudy J Castellani; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  J Pharmacol Exp Ther       Date:  2007-01-17       Impact factor: 4.030

2.  Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia.

Authors:  Juan C Salazar; Frederick A Schmitt; Lei Yu; Marta M Mendiondo; Richard J Kryscio
Journal:  Stat Med       Date:  2007-02-10       Impact factor: 2.373

3.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series.

Authors:  Debby W Tsuang; Robert G Riekse; Kristina M Purganan; Andrew C David; Thomas J Montine; Gerard D Schellenberg; Ellen J Steinbart; Eric C Petrie; Thomas D Bird; James B Leverenz
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

5.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology.

Authors:  Helena C Chui; Chris Zarow; Wendy J Mack; William G Ellis; Ling Zheng; William J Jagust; Dan Mungas; Bruce R Reed; Joel H Kramer; Charles C Decarli; Michael W Weiner; Harry V Vinters
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

Review 6.  Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience.

Authors:  Panteleimon Giannakopoulos; Gabriel Gold; Enikö Kövari; Armin von Gunten; Anouk Imhof; Constantin Bouras; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2006-10-12       Impact factor: 17.088

7.  Diabetes mellitus increases adverse neurocognitive outcome after coronary artery bypass grafting surgery.

Authors:  A Nötzold; K Michel; A A Khattab; H H Sievers; M Hüppe
Journal:  Thorac Cardiovasc Surg       Date:  2006-08       Impact factor: 1.827

Review 8.  Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?

Authors:  Anouk Imhof; Enikö Kövari; Armin von Gunten; Gabriel Gold; Claire-Bénédicte Rivara; François R Herrmann; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  J Neurol Sci       Date:  2007-02-15       Impact factor: 3.181

9.  Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.

Authors:  Bun Sheng; Lik Fai Cheng; Chun Bon Law; Ho Lun Li; Kwan Mo Yeung; Kwok Kwong Lau
Journal:  J Am Geriatr Soc       Date:  2007-06       Impact factor: 5.562

10.  Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

Authors:  John Hardy
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

View more
  154 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

2.  Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors:  Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2010-10-07       Impact factor: 7.376

Review 3.  Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Authors:  Margaret Flanagan; Eric B Larson; Caitlin S Latimer; Brenna Cholerton; Paul K Crane; Kathleen S Montine; Lon R White; C Dirk Keene; Thomas J Montine
Journal:  Biochim Biophys Acta       Date:  2015-08-28

4.  Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Authors:  Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Neurodegeneration-associated instability of ribosomal DNA.

Authors:  Justin Hallgren; Maciej Pietrzak; Grzegorz Rempala; Peter T Nelson; Michal Hetman
Journal:  Biochim Biophys Acta       Date:  2014-01-02

6.  Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects.

Authors:  Elizabeth M Ellison; Melissa A Bradley-Whitman; Mark A Lovell
Journal:  J Mol Neurosci       Date:  2017-09-02       Impact factor: 3.444

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

8.  Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles.

Authors:  Julia Kim; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jul-Sep       Impact factor: 2.703

9.  Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity.

Authors:  David L Masica; Patrick R Sosnay; Karen S Raraigh; Garry R Cutting; Rachel Karchin
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.